Specialist Nurse Sample Clauses

Specialist Nurse. Indication Methotrexate is used in the treatment of adults with severe, active, classical or definite rheumatoid arthritis who are unresponsive or intolerant to conventional therapy and psoriatic arthritis (unlicensed) Dosage and Administration Supply only 2.5 mg strength tablets, as it reduces the risk of accidental overdose (see National Patient Safety Agency Web site ). Issue the methotrexate monitoring booklet to all patients. Update with any dose changes Please note: Oral methotrexate 10 mg strength is not recommended for use in the BSSE health economy. BSR recommendation Typical dose: 7.5–25 mg ONCE weekly; starting dose may vary depending on the severity of the condition and patient characteristics such as age, renal function and other comorbid conditions. The initial dose may be 5–10 mg once weekly, increasing by 2.5–5 mg every 2–6 weeks until disease stabilised. The maximum licensed dose in RA is 25 mg/week. Rarely, the maximum dose can be 30 mg/week. Lower doses should be considered for frail elderly patients who often have poor renal function. If maximum oral dose is not effective or causes intolerance, consider i.m. or subcutaneous route of administration before discontinuation of the drug. Starting dose 7.5 mg – 10 mg per week for two weeks Titration Dependent on tolerability and blood picture:  10 mg per week for four weeks  Then 12.5 mg per week for four weeks Subsequent dosing in increments 2.5 mg every two to four weeks depending on response Range 2.5 mg to 20 mg as a single dose taken on the same day once a week. Spreading the dose over 24 hours helps reduce the risk of nausea NB: Dose can be increased to a maximum of 25 mg per week under specialist guidance (unlicensed) Folic acid 5 mg once a week taken 24 hours after dose of MTX can help reduce some minor side effects By injection Subcutaneous self injection by patient or carer may be used - hospital protocol applies Renal Impairment Methotrexate is contraindicated in the presence of severe/significant renal or significant hepatic impairment. Contra-indications / Special precautions Contraindications  Patients with a known allergic hypersensitivity to methotrexate should not receive methotrexate.  severe/significant renal renal impairment.  significant hepatic impairment. Liver disease including fibrosis, cirrhosis, recent or active hepatitis; active infectious disease; and overt or laboratory evidence of immunodeficiency syndrome(s)  Serious cases of anaemia, leucopenia or thromb...

Specialist Nurse. Indication Treatment of rheumatoid arthritis which has failed to respond to non-steroidal anti-inflammatory drugs (NSAIDs)

Specialist Nurse. Indication Riluzole is indicated to extend life or the time to mechanical ventilation for patients with amyotrophic lateral sclerosis (ALS). Dosage and Administration Treatment should only be initiated by specialist physicians with experience in the management of motor neurone diseases. The recommended daily dose in adults or older people is 100 mg (50 mg every 12 hours) Renal Impairment Riluzole is not recommended for use in patients with impaired renal function Hepatic impairment Riluzole should be prescribed with care in patients with a history of abnormal liver function, or in patients with slightly elevated serum transaminases

Specialist Nurse. Xxxx Xxxxxxxxxx Via (01493) 452216 Via (01493) 452216 Dermatology Consultants: Xx Xxxxxx Xxxxxxx Dermatology Team: Associate Specialist / Specialty Doctor / Specialist Registrar / GPwSI Dermatology / Dermatology Nurse Specialist Via (01493) 452313 Via (01493) 453601 or (01493) 453602 Gastroenterology Consultants: Xx Xxxxx Xxxxxxxxx Via (01493) 452766

Specialist Nurse. Indication For the treatment of the signs and symptoms of early-stage idiopathic Parkinson's disease as monotherapy (i.e. without levodopa) or in combination with levodopa, i.e. over the course of the disease, through to late stages when the effect of levodopa wears off or becomes inconsistent and fluctuations of the therapeutic effect occur (end of dose or 'on-off' fluctuations).

Specialist Nurse. Indication For the treatment of idiopathic Parkinson's disease (PD) as monotherapy (without levodopa) or as adjunct therapy (with levodopa) in patients with end of dose fluctuations.

Specialist Nurse. Indication For pre-operative treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age.

Specialist Nurse. Level 1 RN

Specialist Nurse. Level 3 RN Post graduate tertiary qualifications (Graduate Diploma level and above) in specialisation area - including Palliative Care, Diabetes, continence management, stomal therapy, dementia care, gerontology and Wound Management (Specialisation Area) and 5 years community nursing experience or other relevant nursing experience. 52.00 53.56 55.17 56.82

Specialist Nurse. Indication For treatment of the signs and symptoms of idiopathic Xxxxxxxxx’x disease, alone (without levodopa) or in combination with levodopa.